U.S., July 30 -- An application to own the trademark for 'TRIPTAX' has been filed on Oct. 29, 2021.
Owner(s):
Biomind Labs Inc.; Craigmuir Chambers, Road Town, VIRGIN ISLANDS, BRITISH
Goods and/or Services:
For: Pharmaceutical preparations for treating Treatment Resistant Depression, Major Depressive Disorder, Anxiety, Addictive Disorders, Eating Disorders, Chronic Pain, Fibromyalgia, Inflammation, Cancer, Neurodegenerative Disorders, Neurogenesis, Eye Disorders, Skin disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-07-29&serialNumber=97099590
Disclaimer: Curated by HT Syndication....